Home | Non-food | Drug

Drug

What you need to know after total hip arthroplasty?

Tuesday July 2014 (foodconsumer.org) -- Patients who have received total hip arthroplasty should be carefully followed up to assess the risk factors and reduce the

FDA expands approved use of Imbruvica for chronic lymphocytic leukemia

FDA News Release FDA expands approved use of Imbruvica for chronic lymphocytic leukemia New clinical data supports traditional approval for CLL For Immediate Release July 28, 2014 Release The U.S. Food ...
Full story

Faster, Easier Cures for Hepatitis C

By FDA On this page: A Preventable and Curable Disease Baby Boomers and Hepatitis C Transformative advances in drug treatments approved by the Food and Drug Administration are giving ...
Full story

FDA Teams Up for Novel Campaign on Risks of Decorative Contact Lenses

The Food and Drug Administration (FDA), American Optometric Association (AOA) and the Entertainment Industries Council (EIC) have teamed with entertainment industry-leading artists from the TV series American Horror Story on a first-of-its-kind ...
Full story

Hepatitis C virus antiviral therapy can cause paranoid psychosis, cognitive impairment

Thursday July 24, 2014 (foodconsumer.org) -- A case report suggests that taking hepatitis C virus antiviral therapy may increase risk of paranoid psychosis and cognitive ...
Full story

Anti-pain agent shrinks oral cancers, leaves healthy tissues alone

Contact: Will Sansomsansom@uthscsa.edu210-567-2579University of Texas Health Science Center at San Antonio  Anti-pain agent shrinks oral cancers, leaves healthy tissues alone SAN ANTONIO (July 22, 2014) — Mouse ...
Full story

Statin use decreases the risk of Barrett's esophagus

Contact: Rachel Steigerwaldmedia@gastro.org301-272-1603American Gastroenterological Association  Statin use decreases the risk of Barrett's esophagus Bethesda, MD (July 23, 2014) — Statins, a class of drugs commonly used to ...
Full story

REBEL Platinum Chromium Coronary Stent System

REBEL Platinum Chromium Coronary Stent System (Monorail and Over-the-Wire) - P130030 This is a brief overview of information related to FDA’s approval to market this product. ...
Full story

FDA approves Zydelig (idelalisib) to treat blood cancers - news release

FDA News Release FDA approves Zydelig for three types of blood cancers For Immediate Release July 23, 2014 Release The U.S. Food and Drug Administration today approved Zydelig (idelalisib) to ...
Full story

FDA approves Idelalisib for treatment of relapsed chronic lymphocytic leukemia

U.S. Food and Drug Administration (FDA) approved idelalisib (Zydelig tablets, Gilead Sciences, Inc.) for the treatment of patients with relapsed chronic lymphocytic leukemia (CLL), in combination with rituximab, for whom rituximab alone would be considered appropriate therapy due to other co-morbidities. July 23, 2014. More Information...
Full story
1 2 3 4 5 6 7 8 9 10 next last total: 999 | displaying: 1 - 10